NXL
NXL
NASDAQ · Health Care

Nexalin Technology Inc

$0.36
-0.01 (-3.14%)
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +2,225.6% upside
Low Target $5.74
Average Target $8.47
High Target $10.28
Current Price $0.36
Current
$0.36
Target
$8.47
$5.74 $8.47 avg $10.28
Scenario Analysis
Bear Case
$5.74
1,476.1%
Low target
Base Case
$8.47
+2,225.6%
Avg target
Bull Case
$10.28
+2,722.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.31
-84.2% from high
52-Week Low
$0.36
+0.0% from low
Target vs 52W High
$8.47
+266.7% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +8.6%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +19.2%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -53.0%
SYK
Stryker Corp
Strong Buy 37 76% $338.36 +3.0%
MDT
Medtronic Plc
Buy 38 63% $192.46 +122.1%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -75.1%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -64.9%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +117.0%